Cyprus Mail
Europe Health World

EU regulator starts real-time review of Merck’s Covid-19 pill

file photo: people walk at a crossing in shibuya shopping area, amid the coronavirus disease (covid 19) pandemic, in tokyo
While vaccines are the main weapons against COVID-19, Merck's experimental pill molnupiravir could be a game-changer after studies showed it could halve the chances of dying or being hospitalised for those most at risk of contracting severe illness

U.S. drugmaker Merck & Co Inc said on Monday the European Union’s drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults.

Under the procedure, also known as a “rolling review”, the European Medicines Agency (EMA) would assess data as soon as it becomes available, instead of waiting for a formal application when all required information has been gathered.

While vaccines are the main weapons against COVID-19, Merck’s experimental pill molnupiravir could be a game-changer after studies showed it could halve the chances of dying or being hospitalised for those most at risk of contracting severe illness.

Merck, which is developing molnupiravir with partner Ridgeback Biotherapeutics, filed for U.S. emergency use authorization for the drug on Oct. 11. A panel of outside advisers to the U.S. health regulator are now slated to meet late in November to discuss whether to authorize the experimental antiviral pill.

Molnupiravir if approved by regulators, would be the first COVID-19 drug administered orally and also the first treatment for mildly ailing patients, whereas existing drugs are mostly used to treat the critically ill.

The drugmaker has a contract with the U.S. government to supply 1.7 million courses of the drug at a price of $700 per course. It also recently signed supply deals with countries including Britain, Malaysia and Singapore.

An EU official told Reuters earlier in the month that the bloc too was also considering signing a supply agreement for the antiviral pill, but would do so only after the company started the process of seeking approval.

Related Posts

France says will fight for every UK fishing licence as European deadline looms

Reuters News Service

Get portion-wise: A ‘handy’ guide to making sure you’re not eating too much

CM Guest Columnist

French warplanes tracked by Russian fighters over Black Sea

Reuters News Service

Why increased rainfall in the Arctic is bad news for the whole world

The Conversation

Acting now on Covid will help avoid lockdown later, Britain’s Javid says

Reuters News Service

EU launches €300bn supply chain programme

Kyriacos Nicolaou